Vision Infinitas
Vision is an AI-driven diabetes management platform that provides personalized, precise guidance based on continuous glucose monitoring (CGM) and insulin data. It offers optimization advice for basal rates, insulin-to-carb ratios, and insulin sensitivity factors, along with nutrition and exercise recommendations and mental health support. Developed with leading health experts and trained on extensive diabetes-related content, Vision serves patients at all stages of diabetes management, from newly diagnosed to experienced users, and supports parents managing children's care. The platform is investigational and part of a formal research study working towards FDA clearance, emphasizing data privacy and continuous learning. Vision aims to address the shortage of endocrinologists by delivering expert-level insights instantly and 24/7, enhancing both patient self-management and clinician efficiency.
Vision Infinitas
Vision is an AI-driven diabetes management platform that provides personalized, precise guidance based on continuous glucose monitoring (CGM) and insulin data. It offers optimization advice for basal rates, insulin-to-carb ratios, and insulin sensitivity factors, along with nutrition and exercise recommendations and mental health support. Developed with leading health experts and trained on extensive diabetes-related content, Vision serves patients at all stages of diabetes management, from newly diagnosed to experienced users, and supports parents managing children's care. The platform is investigational and part of a formal research study working towards FDA clearance, emphasizing data privacy and continuous learning. Vision aims to address the shortage of endocrinologists by delivering expert-level insights instantly and 24/7, enhancing both patient self-management and clinician efficiency.
TL;DR
Product: AI-driven diabetes management platform using CGM and insulin data
Clinical status: Investigational; advanced features available via enrollment in the Vision Diabetes Health Study
Key capabilities: Optimization advice for basal rates, insulin-to-carb ratios, insulin sensitivity factors; nutrition, exercise, and mental-health support
Regulatory direction: Working toward formal research study status with communications involving the FDA
Company Overview
Problem Domain
Diabetes self-management and clinical decision support
Industry
Health / Medical
Funding Track Record
Total Funding: 0.00 USD